Wire · opportunities
Coreline Soft Secures 13th US FDA Clearance, Expanding AI-Powered CT Imaging into ...
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 26 October 2026 · Fusion42 review
Coreline Soft secured its 13th FDA 510(k) clearance for AVIEW Aorta Metrics, expanding its AI-powered chest CT imaging capabilities in the U.S. from lung and coronary artery analysis to automated aortic quantitative assessment. The new software automates aortic segmentation and diameter measurement, supporting integration into clinical workflows and advancing multi-disease quantitative imaging analysis.
This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure, and 4 sources have reported it between 19 Oct 2026 and 26 Oct 2026.
◆ ◆ The Wire takeaway
FDA clearance for automated aortic analysis opens the door for you to embed cardiovascular AI deeply into radiology workflows and lung screening programs. Your clinical product now needs seamless integration with established imaging systems to capture this growing market.
◆ Coverage
4 sources · first reported 19 Oct 2026 · latest 26 Oct 2026
◆ Related on Wire
◆ Topics